GL Pharm Tech Corp. (KOSDAQ:204840)
South Korea · Delayed Price · Currency is KRW 924.00
-31.00 (-3.25%)
At close: Jun 1, 2026
GL Pharm Tech Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -131.58 | 12.49 | -2,337 | -3,749 | -790.17 | -3,727 |
Depreciation & Amortization | 889.68 | 1,002 | 1,710 | 2,138 | 2,145 | 2,040 |
Loss (Gain) From Sale of Assets | - | - | -17.5 | -0.44 | -1,714 | 24.82 |
Asset Writedown & Restructuring Costs | - | - | - | - | - | 278.13 |
Loss (Gain) From Sale of Investments | - | - | - | -12.02 | -6.85 | - |
Loss (Gain) on Equity Investments | -273.93 | -279.09 | -20.13 | 13.13 | - | - |
Stock-Based Compensation | 14.2 | 14.2 | - | - | - | 114.28 |
Provision & Write-off of Bad Debts | -9.77 | -8.16 | -174.41 | 35.19 | -15.99 | 26.76 |
Other Operating Activities | 157 | 84.93 | 226.9 | -147.96 | -742.45 | 470.67 |
Change in Accounts Receivable | -1,609 | -1,295 | -11.43 | -139.29 | -2,019 | 15.88 |
Change in Inventory | -1,111 | -2,210 | -1,949 | -988.09 | -2,192 | -579.06 |
Change in Accounts Payable | 233.61 | 507.16 | -593.43 | -540.35 | 2,481 | -271.64 |
Change in Other Net Operating Assets | -833.79 | 1,048 | -1,481 | -369.33 | 1,585 | -663.83 |
Operating Cash Flow | -2,735 | -1,124 | -4,648 | -3,760 | -1,269 | -2,271 |
Capital Expenditures | -3,137 | -3,203 | -391.81 | -579.32 | -6,438 | -1,328 |
Sale of Property, Plant & Equipment | 18 | - | 18.18 | 0.44 | 2,095 | 2.95 |
Sale (Purchase) of Intangibles | -1,219 | -1,219 | -1,355 | - | -7.02 | -7.96 |
Investment in Securities | 200.87 | - | - | 26.92 | -1,000 | -506.25 |
Other Investing Activities | 107.72 | 47.93 | 6.74 | -12.59 | -12.61 | -45.61 |
Investing Cash Flow | -4,006 | -4,340 | -1,580 | -570.14 | -5,435 | -1,897 |
Short-Term Debt Issued | - | 6,000 | 1,000 | 3,900 | 1,550 | 500 |
Long-Term Debt Issued | - | 3,930 | - | 5,810 | 10,400 | - |
Total Debt Issued | 11,080 | 9,930 | 1,000 | 9,710 | 11,950 | 500 |
Short-Term Debt Repaid | - | -2,141 | -1,917 | -1,550 | -1,500 | -513.3 |
Long-Term Debt Repaid | - | -3,822 | -2,013 | -4,409 | -4,453 | -453.73 |
Total Debt Repaid | -7,814 | -5,963 | -3,930 | -5,959 | -5,953 | -967.03 |
Net Debt Issued (Repaid) | 3,266 | 3,967 | -2,930 | 3,751 | 5,997 | -467.03 |
Issuance of Common Stock | 275.55 | 275.55 | 9,280 | 75 | 75 | 412.88 |
Other Financing Activities | -0 | -0 | 0 | 0 | -0.98 | 921.82 |
Financing Cash Flow | 3,542 | 4,243 | 6,350 | 3,826 | 6,071 | 867.67 |
Foreign Exchange Rate Adjustments | - | - | - | - | -19.66 | - |
Miscellaneous Cash Flow Adjustments | -0 | -0 | - | - | -896.68 | 0 |
Net Cash Flow | -3,200 | -1,222 | 121.95 | -503.67 | -1,549 | -3,301 |
Free Cash Flow | -5,871 | -4,327 | -5,039 | -4,339 | -7,707 | -3,600 |
Free Cash Flow Margin | -15.93% | -12.27% | -19.35% | -16.67% | -46.07% | -28.97% |
Free Cash Flow Per Share | -80.56 | -56.10 | -66.83 | -69.72 | -124.25 | -70.78 |
Cash Interest Paid | 586.89 | 573.14 | 777.13 | 788.02 | 382.07 | 349.6 |
Cash Income Tax Paid | 6.87 | -12.3 | 19.24 | -19.23 | 8.17 | 22.53 |
Levered Free Cash Flow | -4,655 | -5,506 | -4,615 | -2,672 | -6,965 | -2,882 |
Unlevered Free Cash Flow | -4,264 | -5,137 | -4,134 | -2,183 | -6,699 | -2,340 |
Change in Working Capital | -3,380 | -1,950 | -4,035 | -2,037 | -144.54 | -1,499 |